OBJECTIVE: The purpose of this study was to describe recent trends in folic acid awareness and use in the periconceptional period among pregnant women in relation to maternal sociodemographic and other relevant factors. STUDY DESIGN: From 1988 to 2002, 16,555 women from the Slone Epidemiology Center Birth Defects Study were interviewed about medication use before and during pregnancy (which included multivitamins and folic acid), about whether they were aware of any vitamins that might decrease the risk of birth defects, and about sociodemographic and medical factors. RESULTS: Awareness of folic acid benefits increased from 0 in 1988 to 50% in 1996 and thereafter. The use of folic acid in the periconceptional period increased from 15% in 1988 to 40% in the last few years. Maternal education was a strong independent predictor of both awareness and use as were ethnicity, whether the pregnancy was wanted, family income, and whether a health care provider was consulted before planning. CONCLUSION: Promoting the use of folic acid supplements, particularly among these disadvantaged groups, is essential to further decrease the prevalence of neural tube defects.
OBJECTIVE: The purpose of this study was to describe recent trends in folic acid awareness and use in the periconceptional period among pregnant women in relation to maternal sociodemographic and other relevant factors. STUDY DESIGN: From 1988 to 2002, 16,555 women from the Slone Epidemiology Center Birth Defects Study were interviewed about medication use before and during pregnancy (which included multivitamins and folic acid), about whether they were aware of any vitamins that might decrease the risk of birth defects, and about sociodemographic and medical factors. RESULTS: Awareness of folic acid benefits increased from 0 in 1988 to 50% in 1996 and thereafter. The use of folic acid in the periconceptional period increased from 15% in 1988 to 40% in the last few years. Maternal education was a strong independent predictor of both awareness and use as were ethnicity, whether the pregnancy was wanted, family income, and whether a health care provider was consulted before planning. CONCLUSION: Promoting the use of folic acid supplements, particularly among these disadvantaged groups, is essential to further decrease the prevalence of neural tube defects.
Authors: S Temel; E Birnie; H M Sonneveld; A J J Voorham; G J Bonsel; E A P Steegers; S Denktaş Journal: Int J Public Health Date: 2012-08-08 Impact factor: 3.380
Authors: S L Carmichael; G M Shaw; W Yang; C Laurent; A Herring; Marjorie H Royle; M Canfield Journal: Am J Obstet Gynecol Date: 2006-01 Impact factor: 8.661
Authors: Glynda F Sharp; Lorenda A Naylor; Jinwen Cai; Melissa L Hyder; Pradeep Chandra; V James Guillory Journal: Matern Child Health J Date: 2008-09-23
Authors: Anne Lise Bjørke-Monsen; Christine Roth; Per Magnus; Øivind Midttun; Roy M Nilsen; Ted Reichborn-Kjennerud; Camilla Stoltenberg; Ezra Susser; Stein Emil Vollset; Per Magne Ueland Journal: Mol Nutr Food Res Date: 2012-09-24 Impact factor: 5.914
Authors: Kit Sing Au; Phong X Tran; Chester C Tsai; Michelle R O'Byrne; Jone-Ing Lin; Alanna C Morrison; Amy W Hampson; Paul Cirino; Jack M Fletcher; Kathryn K Ostermaier; Gayle H Tyerman; Sabine Doebel; Hope Northrup Journal: Birth Defects Res A Clin Mol Teratol Date: 2008-10